Spotlight Growth
No Result
View All Result
Thursday, July 7, 2022
  • Login
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
No Result
View All Result
No Result
View All Result
Home Bio/Med/Pharma

NeuroMetrix, Inc. (NASDAQ: NURO) Shares Skyrocket After its Wearable Treatment for Fibromyalgia Receives FDA Breakthrough Device Designation

by admin
July 20, 2021
in Bio/Med/Pharma
0
NeuroMetrix NASDAQ NURO Quell FDA Spotlight Growth

NeuroMetrix NASDAQ NURO Quell FDA Spotlight Growth

NeuroMetrix, Inc. (NASDAQ: NURO) is engaged as a medical technology and device company, which is focused on the research, development, and commercialization of non-invasive medical devices for pain and neurological disorders. Shares of the medical device company is skyrocketing 165% through early trading on Tuesday, July 20, 2021. Over the past three months, NeuroMetrix has seen average daily volume of 114,610 shares. However, volume of 80.24 million shares or dollar volume of $567.3 million, has already exchanged hands through early trading Tuesday.

Shares of NeuroMetrix are soaring after the company announced that its Quell wearable device for the treatment of symptoms of fibromyalgia in adults, has received Breakthrough Designation from the U.S. FDA. Quell is designed to be a non-invasive, nerve stimulation device that can automatically adjust stimulating activity to optimal levels for both day and night use.

Furthermore, Quell is the only wearable neurostimulator that is powered by a customized microchip that provides more optimized and adjusted treatment. Quell’s technology is protected by 18 U.S. utility patents.

The FDA’s Breakthrough Designation was given after NeuroMetrix conducted a clinical trial of Quell that involved 119 patients with fibromyalgia. Patients were broken down into two separate groups: one with the active Quell device and the other with a non-active device.

For a period of three months, the 119 patients conducted in-home use of Quell and the control device. After the testing period, the group that received the active Quell device showed 56% of test subjects saw clinically meaningful improvement, compared to only 35% in the control group.

“The Breakthrough Device Designation is an important milestone in the Company’s effort to make Quell technology available to people living with fibromyalgia,” said Shai N. Gozani, M.D., Ph.D., President and CEO of NeuroMetrix. “We are moving forward with a regulatory filing that could position us to launch Quell for this indication in the second half of next year.”

Disclosure: Neither Matt Rego nor Spotlight Growth have any position or relationship with any companies mentioned in this article. No payment was made to create this article. This article should not be taken as a solicitation or recommendation to buy or sell any securities. Please conduct your own research and consult your financial advisor to determine your risk tolerance and investment path. We are not licensed brokers or investment advisors.

Tags: biopharmabiopharmaceuticalsbiotechbiotechnologyCNBCcommon stockday tradingemerging growthfibromyalgiaFox Businesshealthhealth stockshot stocksinvestinginvesting newsinvestmentmanufacturingmedicalmedical devicemedical device stocksmedical technology stocksmedtechmicrocap stocksNASDAQNASDAQ stocksNeuroMetrixNeuroMetrix stocknewsNURONURO newsNURO stockpharmaceuticalspublic companyRobinhoodrobinhood stockssalesservicessmall cap companiessmall cap stockssmall capsSpotlight GrowthSpotlight Growth Stocksstock marketstocksstocks to watchtradingtreatmentwebull
Plugin Install : Widget Tab Post needs JNews - View Counter to be installed
  • Trending
  • Comments
  • Latest
Siyata Mobile NASDAQ SYTA SYTAW SD7 VK7 Purchase Orders Spotlight Growth

New Purchase Orders for SD7 Rugged Device, VK7, and Other Accessories Boost Siyata Mobile’s Outlook (NASDAQ: SYTA)

December 14, 2021
Telcoin TEL Crypto Spotlight Growth

Telcoin (TEL) Quietly Leads a Crypto Remittance Revolution

June 15, 2021
Decentraland (MANA) is the Proof of Concept for the Emerging Metaverse

Decentraland (MANA) is the Proof of Concept for the Emerging Metaverse

November 22, 2021
Alfi NASDAQ ALF Ridesharing Tablet Rollout Spotlight Growth

Alfi, Inc. (NASDAQ: ALF) Climbs 51% After Entering Into Agreement with Miami-Based Fulfillment & Distribution Center For its Ridesharing Digital Tablet Rollout

June 15, 2021
Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

0
Safe-T SFET NASDAQ UN Presentation

Safe-T (NASDAQ: SFET) Has Been Selected to Present at the United Nations’ Office of Information and Communications Technology Event

0
Safe-T Group SFET Q4 FY 2020 Financial Results

Safe-T Group (NASDAQ: SFET) Reports Fourth Quarter and Full Year 2020 Financial Results

0
Safe-T Group NASDAQ SFET FY 2020 Prelim

Safe-T Group Ltd. (NASDAQ: SFET) Estimates Record-High Annual Revenues of Approximately $4.9 Million Representing ~50% Growth YoY 2020

0
Waitr NASDAQ WRTH 7 Eleven Delivery Spotlight Growth

Waitr Holdings (NASDAQ: WTRH) Expands Delivery Reach with New National Collaboration with 7-Eleven

July 6, 2022
Resolute Paper Products NYSE RFP Paper Excellence Group Takeover Spotlight Growth

Resolute Forest Products (NYSE: RFP) Enters into Agreement to be Acquired by Paper Excellence Group for $2.7 Billion

July 6, 2022
Inspira Technologies NASDAQ IINN Hyla Blood Sensor Spotlight Growth

Inspira Technologies (NASDAQ: IINN) Unveils Non-Invasive Blood Sensor that Provides Real-Time Changes in Patients

July 6, 2022
5 Micro-Cap Stocks That Are the Best Performers Through the First Half of 2022 Spotlight Growth

5 Best Performing Micro-Cap Stocks Through the First Half of 2022

July 5, 2022

Recent News

Waitr NASDAQ WRTH 7 Eleven Delivery Spotlight Growth

Waitr Holdings (NASDAQ: WTRH) Expands Delivery Reach with New National Collaboration with 7-Eleven

July 6, 2022
Resolute Paper Products NYSE RFP Paper Excellence Group Takeover Spotlight Growth

Resolute Forest Products (NYSE: RFP) Enters into Agreement to be Acquired by Paper Excellence Group for $2.7 Billion

July 6, 2022

Categories

  • Bio/Med/Pharma
  • Cannabis
  • Commodities
  • Consumer Goods
  • Crowdfunding
  • Crypto Cheat Sheets
  • Cryptocurrency
  • Earnings
  • Entertainment
  • Financials
  • Market News
  • Opinion
  • Politics
  • Real Estate
  • Split Watch
  • Sponsored
  • Store
  • Technology
  • Uncategorized
  • Venture Capital/Private Equity (VC/PE)

Site Navigation

  • Disclosures
  • Terms Of Service
  • Privacy Policy
  • Contact Us
Spotlight Growth

Copyright © 2021 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

No Result
View All Result
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener

Copyright © 2021 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Newsletter Signup

Subscribe to our weekly newsletter below and never miss the latest small/micro-cap analysis and investment news from Spotlight Growth.

Enter your email address

Thanks, I’m not interested